Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Miles, Dale"'
Autor:
Lacy S; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA. slacy@exelixis.com., Yang B; Ann Arbor Pharmacometrics Group, Inc., Ann Arbor, MI, USA., Nielsen J; Ann Arbor Pharmacometrics Group, Inc., Ann Arbor, MI, USA., Miles D; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Nguyen L; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Hutmacher M; Ann Arbor Pharmacometrics Group, Inc., Ann Arbor, MI, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2018 Jun; Vol. 81 (6), pp. 1071-1082. Date of Electronic Publication: 2018 Apr 23.
Autor:
Lacy S; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA. slacy@exelixis.com., Nielsen J; Ann Arbor Pharmacometrics Group, Inc., Ann Arbor, MI, USA., Yang B; Ann Arbor Pharmacometrics Group, Inc., Ann Arbor, MI, USA., Miles D; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Nguyen L; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Hutmacher M; Ann Arbor Pharmacometrics Group, Inc., Ann Arbor, MI, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2018 Jun; Vol. 81 (6), pp. 1061-1070. Date of Electronic Publication: 2018 Apr 17.
Autor:
Miles DR; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Lacy SA; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA. slacy@exelixis.com., Wada DR; Quantitative Solutions, LP 845 Oak Grove #115, Menlo Park, CA, 94025, USA., Milwee S; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Yaron Y; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Nguyen LT; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2017 Aug; Vol. 80 (2), pp. 295-306. Date of Electronic Publication: 2017 Jun 20.
Autor:
Wakelee HA; Stanford Cancer Institute, 875 Blake Wilbur Drive, Rm 2233, Stanford, CA, 94305-5826, USA. hwakelee@stanford.edu., Gettinger S; Yale University Cancer Center, New Haven, CT, USA., Engelman J; Massachusetts General Hospital, Charlestown, MA, USA., Jänne PA; Lowe Center for Thoracic Oncology, Dana Farber Cancer Institute, Boston, MA, USA., West H; Swedish Cancer Institute, Seattle, WA, USA., Subramaniam DS; Department of Hematology and Oncology, Georgetown University Hospital, Washington, DC, USA., Leach J; Park Nicollet Cancer Center, Minneapolis, MN, USA., Wax M; Summit Medical Group, Berkeley Heights, NJ, USA., Yaron Y; Exelixis, South San Francisco, CA, USA., Miles DR; Exelixis, South San Francisco, CA, USA., Lara PN Jr; University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2017 May; Vol. 79 (5), pp. 923-932. Date of Electronic Publication: 2017 Mar 28.
Autor:
Lacy SA; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA. slacy@exelixis.com., Miles DR; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA.; Genentech Inc., South San Francisco, CA, USA., Nguyen LT; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA.; Medivation Inc., San Francisco, CA, USA.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2017 May; Vol. 56 (5), pp. 477-491.
Autor:
Miles D; Genentech (A member of the Roche Group), South San Francisco, CA, USA.; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA., Jumbe NL; Pharmactuarials LLC, Mountain View, CA, USA., Lacy S; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA. slacy@exelixis.com., Nguyen L; Exelixis Inc., 210 East Grand Avenue, South San Francisco, CA, 94080-0511, USA.; Medivation Inc., San Francisco, CA, USA.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2016 Jan; Vol. 55 (1), pp. 93-105.
Autor:
Nguyen L; Exelixis, Inc., So. San Francisco, CA, USA., Holland J; Exelixis, Inc., So. San Francisco, CA, USA., Miles D; Exelixis, Inc., So. San Francisco, CA, USA., Engel C; Celerion, Montreal, Quebec, Canada., Benrimoh N; Celerion, Montreal, Quebec, Canada., O'Reilly T; Celerion, Tempe, AZ, USA., Lacy S; Exelixis, Inc., So. San Francisco, CA, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2015 Sep; Vol. 55 (9), pp. 1012-23. Date of Electronic Publication: 2015 Jun 02.
Autor:
Lacy S; Department of Non-Clinical Development (S.L., B.H., D.M., L.N.) and Translational Medicine (D.A.), Exelixis, Inc., South San Francisco, California; and QPS, LLC, Newark, Delaware (R.W.) slacy@exelixis.com., Hsu B; Department of Non-Clinical Development (S.L., B.H., D.M., L.N.) and Translational Medicine (D.A.), Exelixis, Inc., South San Francisco, California; and QPS, LLC, Newark, Delaware (R.W.)., Miles D; Department of Non-Clinical Development (S.L., B.H., D.M., L.N.) and Translational Medicine (D.A.), Exelixis, Inc., South San Francisco, California; and QPS, LLC, Newark, Delaware (R.W.)., Aftab D; Department of Non-Clinical Development (S.L., B.H., D.M., L.N.) and Translational Medicine (D.A.), Exelixis, Inc., South San Francisco, California; and QPS, LLC, Newark, Delaware (R.W.)., Wang R; Department of Non-Clinical Development (S.L., B.H., D.M., L.N.) and Translational Medicine (D.A.), Exelixis, Inc., South San Francisco, California; and QPS, LLC, Newark, Delaware (R.W.)., Nguyen L; Department of Non-Clinical Development (S.L., B.H., D.M., L.N.) and Translational Medicine (D.A.), Exelixis, Inc., South San Francisco, California; and QPS, LLC, Newark, Delaware (R.W.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2015 Aug; Vol. 43 (8), pp. 1190-207. Date of Electronic Publication: 2015 May 26.
Autor:
Shapiro GI; Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA., McCallum S, Adams LM, Sherman L, Weller S, Swann S, Keer H, Miles D, Müller T, Lorusso P
Publikováno v:
Investigational new drugs [Invest New Drugs] 2013 Jun; Vol. 31 (3), pp. 742-50. Date of Electronic Publication: 2012 Oct 06.